Exchange: NASDAQ·Updated 07:49 PM EDT
RZLT logo

RZLT Rezolute Inc

$4.62
$0.36
(7.23%)
Today
Closed $4.62
$0.08
(1.73%)
After Hours
EarningsSep 16
Mkt Cap$444.87M
Vol1.08M

About RZLT

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.
56

Bullish Sentiment

How do you feel about RZLT?

Advertisement|Remove ads.